megestrol acetate has been researched along with Disease Exacerbation in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (40.91) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 4 (18.18) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, YS; Kim, S; Kim, SW; Kim, YT; Lee, JY; Nam, EJ; Park, E; Woo, HY | 1 |
| Atiomo, W; Clement, NS; Mulvaney, CA; Oliver, TR; Sanner, JR; Shiwani, H | 1 |
| Bulun, SE; Coon, JS; Dyson, M; Kim, JJ; Malpani, S; Mittal, N; Ono, M; Pavone, ME; Schink, JC | 1 |
| Buist, MR; Kenter, GG; van der Velden, J; van Driel, WJ; van Lonkhuijzen, LR; van Meurs, HS | 1 |
| Baiocco, E; Carosi, M; Corrado, G; Vizza, E | 1 |
| Adenis, A; Bonodeau, F; Cazin, JL; Clisant, S; Dansin, E; Dégardin, M; Desauw, C; Fournier, C; Mortier, L; Penel, N; Vanhuyse, M | 1 |
| OH, WK | 1 |
| Fochessati, F; Panzini, I; Poggi, B; Ravaioli, A; Sartori, S; Tassinari, D | 1 |
| Burton, G; Kleeberg, U; Mauriac, L; Osborne, CK; Robertson, JF; Vergote, I | 1 |
| Karakuzu, A; Koc, M; Ozdemir, S | 1 |
| Ali, SM; Brown-Shimer, S; Carney, W; Demers, L; Evans, DB; Hamer, P; Leitzel, K; Lipton, A; Pierce, K | 1 |
| Dahrouge, S; Stewart, DJ | 1 |
| Demers, L; Grossberg, H; Leitzel, K; Lipton, A; Teramoto, Y; Volas, GH | 1 |
| Azab, M; Blomqvist, C; Buzdar, A; Eiermann, W; Howell, A; Jonat, W; Jones, SE; Plourde, PV; Vogel, CL; Webster, A; Wolter, JM | 1 |
| Cavanagh, D; Fiorica, JV; Hoffman, MS; Nicosia, SV; Pinelli, DM; Roberts, WS | 1 |
| Bellmunt, J; Bezwoda, W; Chaudri, HA; Dombernowsky, P; Falkson, G; Fornasiero, A; Gardin, G; Gudgeon, A; Hatschek, T; Hoffmann, W; Hornberger, U; Leonard, R; Michel, J; Morgan, M; Panasci, L; Smith, I; Tjabbes, T; Trunet, PF | 1 |
| Bruera, E; Hewitt, J; Palmer, M; Rapp, E; Thaell, JF; Urtasun, R; Wood, L | 1 |
| Goss, PE; Schwartz, LH; Tannock, IF; Winer, EP | 1 |
| Abrams, J; Aisner, J; Berry, DA; Cirrincione, C; Cooper, MR; Ellerton, J; Henderson, IC; Kirshner, J; Muss, HB; Norton, L; Panasci, L | 1 |
| Adedokun, A; Clark, RA; Hoffman, M; Kissinger, P; Kopicko, JJ; Momodu, I | 1 |
| Arkhipov, A; Bajetta, E; Cervek, J; di Salle, E; Dirix, LY; Dugardyn, JL; Fein, LE; Fowst, C; Jones, SE; Kaufmann, M; Massimini, G; Mennel, RG; Miller, LL; Nasurdi, C; Piscitelli, G; Polli, A; Zilembo, N | 1 |
| Chou, HH; Hsueh, S; Huang, HJ; Lai, CH; Soong, YK; Wang, CB; Wang, CJ | 1 |
2 review(s) available for megestrol acetate and Disease Exacerbation
| Article | Year |
|---|---|
Metformin for endometrial hyperplasia.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Disease Progression; Endometrial Hyperplasia; Female; Humans; Hysterectomy; Megestrol Acetate; Metformin; Middle Aged; Precancerous Conditions; Randomized Controlled Trials as Topic; Recurrence; Uterine Hemorrhage; Uterine Neoplasms | 2017 |
Secondary hormonal therapies in the treatment of prostate cancer.
Topics: Adrenal Cortex Hormones; Androgen Antagonists; Anilides; Biomarkers, Tumor; Disease Progression; Estrogens; Humans; Male; Megestrol Acetate; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome; Tosyl Compounds | 2002 |
11 trial(s) available for megestrol acetate and Disease Exacerbation
| Article | Year |
|---|---|
Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care.
Topics: Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Cyclophosphamide; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Megestrol Acetate; Middle Aged; Neoplasms; Palliative Care | 2010 |
Postmenopausal women who progress on fulvestrant ('Faslodex') remain sensitive to further endocrine therapy.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Double-Blind Method; Down-Regulation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Estradiol; Estrogen Receptor Modulators; Female; Follow-Up Studies; Fulvestrant; Humans; Letrozole; Megestrol Acetate; Middle Aged; Nitriles; Postmenopause; Retrospective Studies; Salvage Therapy; Treatment Outcome; Triazoles | 2003 |
Elevated plasma tissue inhibitor of metalloproteinase-1 level predicts decreased response and survival in metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Disease Progression; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Fadrozole; Female; Humans; Megestrol Acetate; Middle Aged; Prognosis; Receptor, ErbB-2; Survival Rate; Tissue Inhibitor of Metalloproteinase-1 | 2007 |
Serial serum c-erbB-2 levels in patients with breast carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Disease Progression; Double-Blind Method; Enzyme Inhibitors; Fadrozole; Female; Humans; Megestrol; Megestrol Acetate; Placebos; Prognosis; Receptor, ErbB-2; Remission Induction; Treatment Outcome | 1996 |
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Double-Blind Method; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Nitriles; Postmenopause; Prognosis; Survival Rate; Tamoxifen; Triazoles | 1996 |
Chemotherapy plus sequential hormonal therapy for advanced and recurrent endometrial carcinoma: a phase II study.
Topics: Adult; Aged; Carboplatin; Carcinoma; Disease Progression; Drug Therapy, Combination; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Receptors, Estrogen; Receptors, Progesterone; Survival Analysis; Tamoxifen | 1996 |
Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.
Topics: Administration, Oral; Aged; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Letrozole; Megestrol Acetate; Middle Aged; Nitriles; Survival Rate; Triazoles | 1998 |
Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P-glycoprotein-mediated drug resistance in the first-line management of small-cell lung carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Disease-Free Survival; Double-Blind Method; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lung Neoplasms; Male; Megestrol Acetate; Middle Aged; Neoplasm Proteins; Vincristine | 1998 |
Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients. North American Vorozole Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Enzyme Inhibitors; Female; Humans; Megestrol Acetate; Middle Aged; Postmenopause; Triazoles | 1999 |
Dose-response trial of megestrol acetate in advanced breast cancer: cancer and leukemia group B phase III study 8741.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Megestrol Acetate; Middle Aged; Prospective Studies; Survival Rate | 1999 |
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Androstadienes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease Progression; Double-Blind Method; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Pain; Postmenopause; Quality of Life; Survival Analysis; Tamoxifen; Treatment Outcome | 2000 |
9 other study(ies) available for megestrol acetate and Disease Exacerbation
| Article | Year |
|---|---|
Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Biomarkers; Biopsy; Disease Progression; DNA Mismatch Repair; DNA Polymerase II; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Humans; Hysterectomy; Intrauterine Devices, Medicated; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Mutation; Neoplasm Recurrence, Local; Prognosis; Receptors, Progesterone; Retrospective Studies; Tumor Suppressor Protein p53; Young Adult | 2021 |
Fenretinide: a novel treatment for endometrial cancer.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Progression; Endometrial Neoplasms; Female; Fenretinide; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Megestrol Acetate; Membrane Proteins; Mice, Nude; Vitamin A; Xenograft Model Antitumor Assays | 2014 |
Evaluation of response to hormone therapy in patients with measurable adult granulosa cell tumors of the ovary.
Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Chemotherapy, Adjuvant; Disease Progression; Disease-Free Survival; Female; Goserelin; Granulosa Cell Tumor; Humans; Letrozole; Megestrol Acetate; Middle Aged; Nitriles; Ovarian Neoplasms; Ovariectomy; Radiotherapy, Adjuvant; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Salpingectomy; Tamoxifen; Triazoles | 2015 |
Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.
Topics: Abortion, Spontaneous; Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Endometrioid; Chemotherapy, Adjuvant; Disease Progression; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy; Hysteroscopy; Laparoscopy; Megestrol Acetate; Neoplasm Staging; Ovariectomy; Ovulation Induction; Precancerous Conditions; Pregnancy; Radiotherapy, Adjuvant; Treatment Failure | 2008 |
Rapid progression of advanced "hormone-resistant" prostate cancer during palliative treatment with progestins for cancer cachexia.
Topics: Aged; Antineoplastic Agents, Hormonal; Cachexia; Disease Progression; Drug Resistance, Neoplasm; Humans; Male; Megestrol Acetate; Palliative Care; Prostatic Neoplasms; Time Factors | 2003 |
Multiple cutaneous metastases from male breast carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Epirubicin; Fatal Outcome; Fluorouracil; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mastectomy, Radical; Megestrol Acetate; Middle Aged; Paclitaxel; Palliative Care; Skin Neoplasms | 2006 |
Response of brain metastases from breast cancer to megestrol acetate: a case report.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Cerebellar Neoplasms; Combined Modality Therapy; Disease Progression; Fatal Outcome; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local | 1995 |
Characteristics of HIV-infected men with low serum testosterone levels.
Topics: Adult; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Candidiasis; Cross-Sectional Studies; Disease Progression; Esophageal Diseases; HIV Infections; HIV Wasting Syndrome; Humans; Longitudinal Studies; Male; Megestrol Acetate; Prognosis; Testosterone | 1999 |
Fertility-preserving treatment in young patients with endometrial adenocarcinoma.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Disease Progression; Endometrial Neoplasms; Female; Fertility; Gonadotropin-Releasing Hormone; Humans; Megestrol; Megestrol Acetate; Pelvis; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Treatment Outcome; Ultrasonography | 2002 |